These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27766828)

  • 1. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Oct; 91(42):485-99. PubMed ID: 27766828
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
    [No Abstract]   [Full Text] [Related]  

  • 3. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
    [No Abstract]   [Full Text] [Related]  

  • 6. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
    Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Mar; 91(10):121-32. PubMed ID: 26971356
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2015 Mar; 90(11):97-108. PubMed ID: 25771542
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
    Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Oct; 91(41):469-84. PubMed ID: 27758094
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus.
    Pu J; Wang S; Yin Y; Zhang G; Carter RA; Wang J; Xu G; Sun H; Wang M; Wen C; Wei Y; Wang D; Zhu B; Lemmon G; Jiao Y; Duan S; Wang Q; Du Q; Sun M; Bao J; Sun Y; Zhao J; Zhang H; Wu G; Liu J; Webster RG
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):548-53. PubMed ID: 25548189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flu 2014].
    Vaqué Rafart J; Pumarola Suñé T
    Med Clin (Barc); 2014 Mar; 142(6):255-8. PubMed ID: 24594075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.